Mostrar 1 - 17 resultats de 17 per cerca 'Mark Salvati (14962400)', hora de la petició: 0.01sec
Refinar resultats
-
1
-
2
-
3
-
4
FigureS3 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
5
FigureS9 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
6
FigureS5 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
7
FigureS2 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
8
FigureS10 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
9
-
10
-
11
FigureS1 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
12
FigureS4 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
13
FigureS6 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
14
FigureS7 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
15
-
16
FigureS8 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer per Jonathan Chou (14957015)
Publicat 2025Altres autors: -
17